Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 3 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S3134Referred to Committee

Combating Counterfeit Pharmaceuticals Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-06
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Tom Cotton
Tom Cotton
Republican · AR · Senator
Votes with party: 76.9% (876 recorded votes)

Full profile: /officials/C001095

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Pete Ricketts (R-NE)Original· 2025-11-06

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

2025-11-06

Source: Congress.gov

Committee Activity

Currently in

  • Senate Committee on Banking, Housing, and Urban AffairsReferred To · 2025-11-06

Previously

  • Banking, Housing, and Urban Affairs CommitteeReferred To · 2025-11-06

Plain-English Summary

This bill aims to crack down on fake and substandard medications that enter the U.S. market from other countries, protecting patients from dangerous drugs that don't contain the promised ingredients or dosages. It likely involves working with international partners to strengthen supply chain security, improve tracking of medications, and increase penalties for those involved in distributing counterfeit drugs. The legislation would affect pharmaceutical companies, importers, healthcare providers, and ultimately patients who rely on safe, authentic medications.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

International Affairs
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S4615Intelligence Authorization Act for Fiscal Year 2027
    Introduced · 2026-08-05
  • S5083Fiscal Sponsorship Transparency Act of 2026
    Referred to Committee · 2026-07-22
  • S4984Restoration of Employment Choice for Adults with Disabilities Act
    Referred to Committee · 2026-07-15
  • S4939Countering CCP Act
    Referred to Committee · 2026-06-24